About Amass

Built for scientific work.
Designed for evidence.

We built Amass because scientific work increasingly depends on fragmented evidence spread across too many systems, tools and teams and time. Search alone is not enough. Teams need infrastructure that helps them retrieve, verify, structure and reuse knowledge without losing the source trail.

Mission

Make scientific intelligence reliable, traceable and reusable.

Life science decisions are only as good as the evidence behind them. But that evidence is often scattered across papers, patents, trials, regulatory sources, internal documents and team knowledge.

Amass turns fragmented scientific knowledge into a shared intelligence layer. Every answer, workflow and output can be traced back to the underlying source — so researchers, investors, developers and strategy teams can work from the same evidence base.

Human judgment stays in control. Amass provides the evidence infrastructure underneath.

500M+documents indexed

6specialized data layers

2022Founded

CopenhagenDenmark

How we got here

From biomedical search
to scientific intelligence infrastructure

Amass started from a simple problem: life science teams make important decisions from evidence that is scattered across data sources and availability.

Our early work focused on biomedical retrieval, helping teams search scientific literature with more precision, coverage and traceability. Since then, Amass has expanded into a broader scientific intelligence layer: connecting multiple evidence sources, structuring them into workflows, and making every answer traceable back to the underlying source.

Today, Amass supports evidence-heavy work across research, due diligence, competitive intelligence, portfolio monitoring, target evaluation and scientific strategy.

Amass *Core

The Amass *Core infrastructure

BioMedCoreBiomedical literature and citations.
ScholarCoreScientific and academic knowledge.
PatentCoreIP, filings and ownership.
TrialCoreClinical trials, sponsors and endpoints.
RegulatoryCoreFDA, EMA and regulatory documents.
WebCoreLive company, market and web intelligence.

App, API and MCP

One scientific intelligence layer, available wherever teams work.

How we work

What makes Amass different

Evidence-first, not answer-first

Amass starts by retrieving the relevant source material, then structures, synthesizes and reasons.

Built for life science complexity

The platform works across data in life sciences, publications, patents, clinical trials, regulatory sources, web data and internal documents.

Traceable by default

Every answer, workflow and output links back to the underlying source, so teams can review, verify and reuse the evidence.

Founders

Science depth. Commercial execution.

Alexander Junge

Co-Founder & CTO

Bioinformatics PhD and former Novo Nordisk data scientist. Built the Amass data engine from the ground up, combining biomedical retrieval, scientific data infrastructure and applied AI for life science workflows.

PhD BioinformaticsNovo Nordisk18,000+ citationsAI/MLScientific retrieval

Henrik Jensen

Co-Founder & CEO

Commercial and organizational lead with experience scaling digital products, fundraising, partnerships and go-to-market. Previously built and exited product-led companies and advised life science and technology organizations.

CEO / GTMIPO experienceExit experienceVC / fundraisingLife science strategy

Team

Built by people who have worked inside the problem

Jörn Petersen

AI & Data Engineer

Founding engineer behind Novo Nordisk's BraiNN biomedical knowledge graph. Builds the data pipelines, retrieval systems and scientific infrastructure behind Amass.

Novo Nordisk BraiNNBiomedical knowledge graphsIBM Watson Health

René Bischoff

Platform and Infra Engineer

Full-stack and infrastructure engineer. First engineer at Pleo and built their infrastructure from the ground up. Builds the platform layer that makes Amass reliable in production.

Platform EngineerInfrastructureAPI and MCP

Lluís Colomer Coll

AI Engineer

Leads development of Amass agents and applied AI workflows. Focused on model orchestration, research workflows and production-grade scientific agents.

MSc Human-Centered AIAmass Agents lead

Emil Cronval

GTM Engineer

Builds the bridge between product, operations and go-to-market. Owns automation, customer workflows and internal systems that help Amass move faster.

AI GTMOperationsAutomationSales workflows

Heidi Noddeland

Business Development

Life science commercial strategy and partnerships. PhD in pharmaceutical sciences with experience in pharma, biotech and innovation consulting.

PhD Pharmaceutical SciencesLEO PharmaBioInnovation / consultingPartnerships

Niels Andersen

Product & UX Strategy

Shapes product direction and user-facing workflows. 20 years of product strategy and design across enterprise and startup environments.

Product strategyUXEnterprise softwareLife science workflows

We're hiring

ML / Research Engineer

Work on retrieval, grounding, and scientific reasoning across 500M+ documents. Strong ML fundamentals, comfort shipping to production.

Copenhagen · on-siteFull-time

See the role→

We're hiring

Platform Engineer

Scale the infrastructure that serves the Amass cores and API to research teams worldwide. Backend, data, and distributed systems chops.

Copenhagen · on-siteFull-time

See the role→

Open application

Don't see your role?

If you're strong in life science, infrastructure, or AI — and you'd like to build the research foundation we wish existed — we'd like to talk.

All disciplines

Get in touch→

Board

Our strategic backbone

A board of seasoned leaders whose global perspectives and proven track records provide the governance and insight that drive our mission forward.

Dr. Christian Thirion

Chairman

Founder and MD of SIRION Biotech GmbH, a Munich-based biotech firm recognized as a leader in viral vector development and cell modeling for preclinical research (sold to Revvity). Also serves as board member at Lysomab and Hervolution.

Tommy Ahlers

Board member

Partner at Giant Ventures. Former Danish Minister for Science and Higher Education and MP. Founded/built ZYB and Podio (exit to Vodafone and Citrix) and chair of Peakon and Lix.

Bodil Sidén

Board member

General Partner at KOST Capital, an early-stage VC investing in food and bioeconomy-driven innovation. Former Partner at blq invest, backing early-stage ventures like Ingrid, Bower and Hydda.